ADC Therapeutics SA
ADCT
$1.22
$0.108.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -157.85M | -212.15M | -214.91M | -227.29M | -240.05M |
| Total Depreciation and Amortization | 3.28M | 3.33M | 3.41M | 3.39M | 3.27M |
| Total Amortization of Deferred Charges | 902.00K | 2.15M | 2.46M | 2.69M | 3.02M |
| Total Other Non-Cash Items | 26.01M | 72.45M | 72.20M | 72.38M | 70.81M |
| Change in Net Operating Assets | 3.83M | 601.00K | -8.40M | 1.44M | 44.27M |
| Cash from Operations | -123.84M | -133.62M | -145.25M | -147.39M | -118.69M |
| Capital Expenditure | -867.00K | -1.10M | -1.55M | -2.73M | -3.22M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -867.00K | -1.10M | -1.55M | -2.73M | -3.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 99.10M | 99.05M | 99.40M | 705.00K | 774.00K |
| Repurchase of Common Stock | -2.04M | -880.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 73.10M | 73.10M |
| Cash from Financing | 97.05M | 98.17M | 99.40M | 73.81M | 73.88M |
| Foreign Exchange rate Adjustments | -83.00K | 412.00K | 3.00K | 52.00K | 184.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.73M | -36.14M | -47.39M | -76.26M | -47.84M |
